Skip to main content

Alpine Immune Sciences to Participate in the Evercore ISI HealthconX Conference

Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced that the Company will participate in the upcoming Evercore ISI HealthconX Conference, November 28-30, 2023.

  • Thursday, November 30th, the Company will participate in a fireside chat at 7:55 am ET/4:55 am PT and also host investor meetings.

A live webcast of the fireside chat will be available in the investor relations section of the Company’s website at https://ir.alpineimmunesciences.com/events and a replay will be available on the Company's website for 90 days following the event.

About Alpine Immune Sciences

Alpine Immune Sciences is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on X and LinkedIn.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  214.07
+1.03 (0.49%)
AAPL  258.20
+5.91 (2.34%)
AMD  236.64
+3.56 (1.53%)
BAC  51.52
+0.24 (0.47%)
GOOG  256.00
+2.21 (0.87%)
META  723.89
+6.98 (0.97%)
MSFT  514.37
+0.79 (0.15%)
NVDA  182.16
-1.06 (-0.58%)
ORCL  283.67
-7.64 (-2.62%)
TSLA  442.73
+3.42 (0.78%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.